Novo Nordisk A/S: Diabetes Mellitus, Type 1 trials

The registry lists 226 Diabetes Mellitus, Type 1 studies with Novo Nordisk A/S as lead sponsor. 2 are open to participants now and 32 have results posted.

Phase 1 75Phase 2 8Phase 3 53Phase 4 12No phase 78(a study in two phases counts in both)

Studies

Page 2 of 3. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• An International Survey on Hypoglycaemia Among Insulin-treated Patients With DiabetesCompletedNCT01696266
• A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 DiabetesCompletedNCT01682902Phase 1
• French Observational Survey to Assess Hypoglycaemia in Insulin-treated Diabetic PatientsCompletedNCT01628341
• A Trial Investigating the Pharmacodynamic Properties of NN1218 in Subjects With Type 1 DiabetesCompletedNCT01618188Phase 1
• A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With Type 1 DiabetesCompletedNCT01590836Phase 1
• Efficacy and Safety of Levemir® Used as Basal InsulinCompletedNCT01548248
• Observational Study to Evaluate the Safety of Levemir® in Patients With DiabetesCompletedNCT01545791
• Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and HyposCompletedNCT01542489
• The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment SatisfactionCompletedNCT01542476
• Evaluation of the Use of Levemir® in Insufficiently Controlled Patients With Type 1 or Type 2 DiabetesCompletedNCT01542463
• Pharmacokinetics of Insulin Detemir in Subjects With Type 1 DiabetesCompletedNCT01542450Phase 1
• An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes MellitusCompletedNCT01542424
• Special Survey for Patients With Type 1 or Type 2 DiabetesCompletedNCT01538589
• Paediatric Subjects - Special SurveyCompletedNCT01538576
• The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 DiabetesCompletedNCT01536665Phase 1
• Post Marketing Surveillance Study of Biphasic Insulin Aspart 30CompletedNCT01536613
• Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 DiabetesCompletedNCT01536028Phase 1
• Comparison of Single Dose and Steady State Pharmacodynamics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 DiabetesCompletedNCT01526941Phase 1
• Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 DiabetesCompletedNCT01524809Phase 1
• Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With DiabetesCompletedNCT01520818Phase 3
• Evaluation of Safety and Parameters of Application TechniqueCompletedNCT01516242
• Diabetes Attitudes Wishes and NeedsCompletedNCT01507116
• Within-subject Variability of Insulin Detemir in Children and Adolescents With Type 1 DiabetesCompletedNCT01497574Phase 1
• To Estimate the Percentage of Children and Adolescents in Tunisia With Acceptably Controlled Diabetes Mellitus Type 1CompletedNCT01493388
• Observational Study With InnoLet® in Daily Clinical PracticeCompletedNCT01492959
• Observational Study With Mixtard® 30 NovoLet® to Assess Patient SatisfactionCompletedNCT01492218
• NovoLet® Acceptance Study Within the Hospital Practise in IndonesiaCompletedNCT01492205
• NovoLet® Surveillance Study on Using Human Insulin System in IndonesiaCompletedNCT01492153
• Surveillance Study of NovoRapid® for New Drug Re-examinationCompletedNCT01490112
• Special Survey for Type 1 or Type 2 Diabetic PatientsCompletedNCT01487408
• Special Survey for Paediatric SubjectsCompletedNCT01487382
• Special Survey of Production of Insulin Aspart Specific AntibodyCompletedNCT01487369
• Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 DiabetesCompletedNCT01486940Phase 3
• Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 DiabetesCompletedNCT01486381Phase 3
• A Trial Investigating the Pharmacokinetic Properties of Formulations of NN1218 in Subjects With Type 1 DiabetesCompletedNCT01469143Phase 1
• Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 DiabetesCompletedNCT01467323Phase 3
• Safety and Efficacy of Insulin Aspart in Children With Type 1 DiabetesCompletedNCT01467141Phase 4
• Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 DiabetesCompletedNCT01464099Phase 1
• A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 DiabetesCompletedNCT01455142Phase 1
• Evaluating Safety of NovoPen® 3 and/or FlexPen® Devices in Routine Clinical PracticeCompletedNCT01454024
• Changing Diabetes® World TourCompletedNCT01437072
• A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Children With Type 1 DiabetesCompletedNCT01435642
• A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in IndiaCompletedNCT01351922
• A Trial Investigating the Pharmacokinetic Properties of NN1218 in Subjects With Diabetes Mellitus, Type 1CompletedNCT01296438Phase 1
• Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 DiabetesCompletedNCT01269606Phase 1
• Observational Study of NovoPen Echo® on Safety and Treatment Satisfaction in Children and Adolescents With Type 1 DiabetesCompletedNCT01180530
• A Trial Investigating the Exposure of NN5401 in Young Adults and Elderly Subjects With Type 1 DiabetesCompletedNCT01174303Phase 1
• Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Subjects With Type 1 DiabetesCompletedNCT01173926Phase 1
• A Trial Investigating the Total Exposure of NN5401 (Insulin Degludec/Insulin Aspart) in Children, Adolescents and Adult Subjects With Type 1 DiabetesCompletedNCT01138488Phase 1
• A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 1 DiabetesCompletedNCT01135927Phase 1
• A Trial Investigating NN1218 in Subjects With Type 1 DiabetesCompletedNCT01121289Phase 1
• A Trial Investigating NN1218 in Subjects With Type 1 and Type 2 DiabetesCompletedNCT01121276Phase 1
• A Trial Evaluating the Effect of NN1250 at Steady State Conditions in Subjects With Type 1 DiabetesCompletedNCT01114542Phase 1
• Comparison of Two NN1250 Formulations in Subjects With Type 1 DiabetesCompletedNCT01076634Phase 1
• Effect of NN5401 in Japanese Subjects With Type 1 DiabetesCompletedNCT01051102Phase 1
• A Trial Investigating the Concentration in the Blood of NN1250 in Children, Adolescents and Adults With Type 1 DiabetesCompletedNCT01030926Phase 1
• A Two Part Trial Investigating NN1952 in Healthy Subjects and Subjects With Type 1 and Type 2 DiabetesCompletedNCT01028404Phase 1
• Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 DiabeticsCompletedNCT01002768Phase 1
• Investigation of the Response Relationship of NN5401 in Type 1 DiabeticsCompletedNCT00993096Phase 1
• Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Type 1 DiabeticsCompletedNCT00992537Phase 1
• A Trial Assessing Changes in Blood Sugar and the Number of Periods Where Supplementation of Carbohydrate is Needed to Treat Low Blood Sugar, During Two Different Treatment Regimens of NN1250 in Type 1 DiabeticsCompletedNCT00964964Phase 1
• A Trial Investigating the Effect of NN1250 in Young and Elderly Subjects With Type 1 DiabetesCompletedNCT00964418Phase 1
• A Trial Investigating the Within-subject Variability of NN1250 in Subjects With Type 1 DiabetesCompletedNCT00961324Phase 1
• A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in KoreaCompletedNCT00918151
• A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in TaiwanCompletedNCT00887874
• A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in MalaysiaCompletedNCT00877526
• A Survey to Evaluate Diabetes Management, Control, Complications and Psychosocial Aspects of Diabetic Patients in PhilippinesCompletedNCT00874159
• Observational Study of Type 1 Diabetics Switching From Human Insulins to Modern Insulin AnaloguesCompletedNCT00873639
• Comparison of 2 NovoFine® Needles on the Reflux of InsulinCompletedNCT00872560Phase 3
• Localisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics Using 6 mm and 12 mm Long NeedlesCompletedNCT00871416Phase 3
• Observational Study on Levemir® in Obese Diabetic PatientsCompletedNCT00849342
• Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes and Kidney DiseaseWithdrawnNCT00849316
• A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in BangladeshCompletedNCT00839878
• A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in SingaporeCompletedNCT00836030
• Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 DiabetesCompletedNCT00832182Phase 3
• Observational Study of NovoPen® 4 on Treatment Satisfaction of Insulin Therapy in Type 1 or Type 2 Subjects With Diabetes MellitusCompletedNCT00806858
• A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in ThailandCompletedNCT00805922
• An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of DiabetesCompletedNCT00789711
• A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in IndonesiaCompletedNCT00788853
• Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During HypoglycaemiaCompletedNCT00760448Phase 1
• An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 DiabetesCompletedNCT00738153
• Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of DiabetesCompletedNCT00737776
• Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 DiabetesCompletedNCT00725036Phase 3
• Observational Study to Evaluate the Safety of Levemir® in DiabetesCompletedNCT00706017
• Observational Study to Evaluate the Safety While Using Levemir®CompletedNCT00701155
• Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 DiabetesCompletedNCT00700765
• An Observational Study to Assess Safety and Effectiveness of Intravenous NovoRapid® in Hospitalised SubjectsCompletedNCT00700648
• Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 DiabetesCompletedNCT00699179
• An Observational Study of Efficacy and Safety of Modern Insulin in Diabetes Patients Switched From Anti-diabetic TreatmentCompletedNCT00698269
• Observational Study of Type 1 and Type 2 Diabetes Patients Having Switched From Human Premixes to NovoMix®30CompletedNCT00675493
• Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™CompletedNCT00675220
• Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 DiabetesCompletedNCT00671008
• Observational Study of Patients With Diabetes Using Levemir® FlexPen®CompletedNCT00670683
• Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 DiabetesCompletedNCT00665093
• Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes MellitusCompletedNCT00655200
• Evaluation of Levemir® for the Treatment of Type 1 and 2 DiabetesCompletedNCT00655044
• Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 DiabetesCompletedNCT00617565Phase 3
• Safety of Insulin Detemir in Children With Type 1 DiabetesCompletedNCT00605137Phase 3
• Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Process in Type 1 DiabetesCompletedNCT00604656Phase 3
• Efficacy and the Safety of Insulin Detemir in Subjects With Insulin Requiring DiabetesCompletedNCT00604344Phase 3